Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
$10.93
$4.51
$20.20
$236.61M0.4162,237 shs171,500 shs
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$17.66
-2.4%
$15.67
$9.50
$18.85
$1.60B1.61.22 million shs443,600 shs
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
$0.04
$0.05
$0.03
$13.93
$839K2.0341,315 shs1,279 shs
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
$0.35
-2.8%
$0.96
$0.33
$8.17
$3.74M1.58177,655 shs123,283 shs
Organigram Holdings Inc. stock logo
OGI
Organigram
$1.93
-1.0%
$2.09
$0.97
$2.91
$199.18M1.091.36 million shs775,826 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
0.00%0.00%0.00%0.00%0.00%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
-2.38%-1.83%+6.45%+28.72%+73.31%
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
+4.00%+0.57%-11.60%-35.85%-98.52%
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
-2.67%-8.83%-63.53%-75.35%-90.91%
Organigram Holdings Inc. stock logo
OGI
Organigram
-1.03%+5.46%-23.41%+19.14%-5.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
N/AN/AN/AN/AN/AN/AN/AN/A
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
3.2343 of 5 stars
4.52.00.00.03.41.70.6
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
2.0139 of 5 stars
3.55.00.00.02.40.00.0
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
N/AN/AN/AN/A
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
3.00
Buy$22.5727.81% Upside
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
2.00
HoldN/AN/A
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
3.00
Buy$17.254,827.16% Upside
Organigram Holdings Inc. stock logo
OGI
Organigram
3.00
BuyN/AN/A

Current Analyst Ratings

Latest ADRO, EVLO, OGI, AVDL, and MBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Organigram Holdings Inc. stock logo
OGI
Organigram
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
4/9/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$18.00 ➝ $23.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$27.00 ➝ $29.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$21.00 ➝ $25.00
3/5/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
2/6/2024
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$21.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
$17.26M0.00N/AN/A$4.07 per share0.00
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$27.96M57.21N/AN/A$0.98 per share18.02
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
N/AN/AN/AN/A($0.92) per shareN/A
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
N/AN/AN/AN/A$0.01 per shareN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
$120.01M1.66N/AN/A$2.48 per share0.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
-$82.37M-$5.15N/AN/AN/A-230.92%-101.73%-22.35%N/A
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
-$160.28M-$2.04N/A21.28N/AN/A-198.06%-84.51%5/2/2024 (Estimated)
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
-$114.53M-$13.29N/AN/AN/AN/A-189.58%5/13/2024 (Estimated)
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
-$51.60M-$6.00N/AN/AN/A-433.08%-146.39%5/10/2024 (Estimated)
Organigram Holdings Inc. stock logo
OGI
Organigram
-$184.34M-$0.80N/AN/AN/A-173.48%-30.94%-27.70%4/30/2024 (Estimated)

Latest ADRO, EVLO, OGI, AVDL, and MBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/11/2024Q4 2023
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
-$1.68-$0.71+$0.97-$0.71N/AN/A
3/4/2024Q4 2023
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
-$0.28-$0.32-$0.04-$0.29$17.41 million$19.45 million    
2/13/2024Q1 2024
Organigram Holdings Inc. stock logo
OGI
Organigram
-$0.10-$0.14-$0.04-$0.14$28.61 million$26.78 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
N/AN/AN/AN/AN/A
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
N/AN/AN/AN/AN/A
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
N/AN/AN/AN/AN/A
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
N/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
N/A
8.91
8.91
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
N/A
3.64
3.36
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
N/A
0.48
0.48
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
N/A
0.74
0.74
Organigram Holdings Inc. stock logo
OGI
Organigram
N/A
4.28
2.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
49.93%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
69.19%
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
0.31%
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
9.95%
Organigram Holdings Inc. stock logo
OGI
Organigram
34.63%

Insider Ownership

CompanyInsider Ownership
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
5.90%
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
4.00%
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
1.02%
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
2.10%
Organigram Holdings Inc. stock logo
OGI
Organigram
0.09%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aduro Biotech, Inc. stock logo
ADRO
Aduro Biotech
15216.21 millionN/AOptionable
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
15490.58 million86.95 millionOptionable
Evelo Biosciences, Inc. stock logo
EVLO
Evelo Biosciences
6618.98 million18.79 millionNo Data
Mustang Bio, Inc. stock logo
MBIO
Mustang Bio
8010.39 million10.17 millionNot Optionable
Organigram Holdings Inc. stock logo
OGI
Organigram
984103.20 million103.11 millionOptionable

ADRO, EVLO, OGI, AVDL, and MBIO Headlines

SourceHeadline
Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"
americanbankingnews.com - April 16 at 4:50 AM
Organigram (NASDAQ:OGI) Lifted to Buy at Alliance Global PartnersOrganigram (NASDAQ:OGI) Lifted to Buy at Alliance Global Partners
marketbeat.com - April 15 at 9:11 AM
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
markets.businessinsider.com - April 11 at 1:36 PM
Organigram Recognized for Executive Gender Diversity by the Globe & Mails Women Lead Here Report for the Fourth Consecutive YearOrganigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year
stockhouse.com - April 10 at 5:10 PM
Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)
marketbeat.com - April 5 at 8:21 AM
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
finance.yahoo.com - April 3 at 8:37 AM
Organigrams Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
businesswire.com - April 3 at 8:06 AM
Organigram Successfully Closes Previously Announced Underwritten Public OfferingOrganigram Successfully Closes Previously Announced Underwritten Public Offering
businesswire.com - April 2 at 8:51 AM
Organigram (NASDAQ:OGI) Stock Price Down 6.3%Organigram (NASDAQ:OGI) Stock Price Down 6.3%
marketbeat.com - March 30 at 12:43 AM
Why OrganiGram (OGI) Might Surprise This Earnings SeasonWhy OrganiGram (OGI) Might Surprise This Earnings Season
zacks.com - March 28 at 9:56 AM
Why OrganiGram (OGI) Stock Is DivingWhy OrganiGram (OGI) Stock Is Diving
msn.com - March 27 at 3:18 PM
Organigram Sells Units to Raise C$25 MIllionOrganigram Sells Units to Raise C$25 MIllion
newcannabisventures.com - March 27 at 10:18 AM
Organigram Announces Pricing of Overnight Marketed Public OfferingOrganigram Announces Pricing of Overnight Marketed Public Offering
businesswire.com - March 27 at 8:56 AM
Organigram Announces Launch of Overnight Marketed Public OfferingOrganigram Announces Launch of Overnight Marketed Public Offering
businesswire.com - March 26 at 7:06 PM
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter InvestmentOrganigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
businesswire.com - March 26 at 1:36 PM
OGI Sep 2024 6.000 callOGI Sep 2024 6.000 call
finance.yahoo.com - March 26 at 12:10 AM
OGI Jun 2024 4.000 putOGI Jun 2024 4.000 put
finance.yahoo.com - March 26 at 12:10 AM
Organigram ‘assessing options’ after unfavorable ruling on cannabis ediblesOrganigram ‘assessing options’ after unfavorable ruling on cannabis edibles
mjbizdaily.com - March 26 at 12:10 AM
The Marijuana Stocks Could See A Rise This WeekThe Marijuana Stocks Could See A Rise This Week
marijuanastocks.com - March 24 at 9:40 AM
Organigram Receives Health Canadas Final Redetermination on JoltsOrganigram Receives Health Canada's Final Redetermination on Jolts
businesswire.com - March 22 at 7:00 PM
Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5
investorplace.com - March 21 at 4:05 PM
OGI Apr 2024 2.000 putOGI Apr 2024 2.000 put
finance.yahoo.com - March 17 at 12:08 AM
Top Marijuana Stocks For Trading Today 2024Top Marijuana Stocks For Trading Today 2024
marijuanastocks.com - March 6 at 9:06 AM
2 Top Marijuana Penny Stocks with High Momentum Before March 20242 Top Marijuana Penny Stocks with High Momentum Before March 2024
marijuanastocks.com - March 2 at 11:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aduro Biotech logo

Aduro Biotech

NASDAQ:ADRO
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
Avadel Pharmaceuticals logo

Avadel Pharmaceuticals

NASDAQ:AVDL
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Evelo Biosciences logo

Evelo Biosciences

NASDAQ:EVLO
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Mustang Bio logo

Mustang Bio

NASDAQ:MBIO
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.
Organigram logo

Organigram

NASDAQ:OGI
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.